Trial intelligence / Profile preview

Hyaluronidase versus adrenaline as adjuvants to bupivacaine in ultrasound-guided supraclavicular brachial plexus block

PACTR201710002718112Recruiting

Sponsor
Zagazig University Hospitals
Start
Sep 2017
Modality
Small Molecules, Recombinant Proteins and Enzymes, Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Trial of bupivacaine, hyaluronidase and epinephrine (3 arms), sponsored by Zagazig University Hospitals. Primary endpoint: Time to achieve complete sensory block. Started Sep 2017; status: recruiting.

02

Drugs

bupivacainehyaluronidaseepinephrine

Beyond the preview

Go deeper on PACTR201710002718112.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201710002718112.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call